(1)
Assessment of Serum Podocalyxin As a Biomarker for Diabetic Nephropathy in Type 2 Diabetes Patients in Duhok City. JLBSR 2022, 3 (02), 71-75. https://doi.org/10.38094/jlbsr30275.